Table 3

Demographic characteristics and lifestyle factors of cases (survival analysis)
Variables Deceased (n = 106)* Alive (n = 202)* P-value
Age at recruitment 60.4 (12.18) 59.8 (11.66) 0.66
Sex:
Men 56 (52.8) 103 (51.0)
Women 50 (47.2) 99 (49.0) 0.76
FH risk:
Low 78 (82.1) 148 (77.1)
Medium/High 17 (17.9) 44 (22.9) 0.33
Smoking status:
Never 31 (48.4) 71 (42.8)
Former 20 (31.3) 67 (40.4)
Current 13 (20.3) 28 (16.9) 0.44
Physical activity (cycling & other sport in hours/week) ‡
0 37 (62.7) 88 (54.3)
0-3.5 6 (10.2) 50 (30.9)
3.5-7 6 (10.2) 11 (6.8)
>7 10 (17.0) 13 (8.0) 0.008
BMI‡:
<25 24 (36.4) 68 (41.7)
25-29.9 31 (47.0) 71 (43.6)
≥30 11 (16.7) 24 (14.7) 0.75
Alcohol intake (g/day)‡ 13.1 12.6 0.29
(16.0) (14.2)
Energy intake (kJ/day)‡ 11222.2 10939.5 0.54
(3886.9) (3909.0)
DEPCAT††
1 11 (10.4) 22 (10.9)
2 23 (21.7) 53 (26.2)
3 25 (23.6) 52 (25.7)
4 29 (27.4) 40 (19.8)
5 9 (8.5) 15 (7.4)
6 9 (8.5) 18 (8.9)
7 0 (0) 2 (1.0) 0.72
PMH Bowel disease (incl. IBS) 6 (9.1) 12 (7.3) 0.65
PMH Cancer 6 (9.1) 17 (10.3) 0.78
Statin use: at least 1 prescription dispensed 2/12 pre-recruitment 8 (7.6) 16 (7.9) 0.91
Statin use: at least 1 prescription dispensed 7/12 pre-recruitment 8 (7.6) 15 (7.4) 0.97
Statin use: 2+ prescriptions dispensed. First being at least 2/12 pre-recruitment 8 (7.6) 15 (7.4) 0.97
Statin use: 2+ prescriptions dispensed. First prescription at least 7/12 pre-recruitement 8 (7.6) 14 (6.9) 0.84
Regular use of NSAIDs**:
Yes 47 (73.4) 127 (78.4)
No 17 (26.6) 35 (21.6) 0.43
HRT use:
Yes 7 (26.9) 23 (28.8)
No 19 (73.1) 57 (71.3) 0.86
Hormonal contraception use:
Yes 6 (23.1) 30 (37.5)
No 20 (76.9) 50 (62.5) 0.18

Lakha et al.

Lakha et al. BMC Cancer 2012 12:487   doi:10.1186/1471-2407-12-487

Open Data